Literature DB >> 17126750

Photodynamic therapy in dermatology: the next five years.

Michael H Gold1.   

Abstract

Photodynamic therapy (PDT) has had a rapid insurgence into the dermatologic armamentarium of clinicians from all over the world. Its use in actinic keratoses and in non-melanoma skin cancers is well described. Additional uses, including its use in the treatment of photorejuvenation and acne vulgaris and related disorders, are gaining more widespread use. More recent descriptions, including its potential use as a chemoprevention agent, warrant further investigations and discussions. PDT is a global treatment modality and physicians and investigators must view the therapy as such, and use the best photosensitizer for the best indication, and continue to evaluate new approaches to maximize the use of PDT in dermatology.

Entities:  

Mesh:

Year:  2007        PMID: 17126750     DOI: 10.1016/j.det.2006.09.013

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  1 in total

1.  Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.

Authors:  Christine B Warren; Sara Lohser; Lauren C Wene; Brian W Pogue; Philip L Bailin; Edward V Maytin
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.